Skip to main content

Table 2 RP gene copy number alterations associated with t-SNE clusters

From: Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers

Genes Type Location Cohort Cluster Frequency
RPL19, RPL23 Amplification 17q12 BRCA 1 98.9%, 83.1%
RPL8, RPL30 Amplification 8q22 BRCA 3 100%, 97.5%
   LIHC 3 98.8%, 98.8%
   PRAD 2 95.1%, 97.5%
   LUNG 1 100%, 94.3%
   SKCM 2 94.2%, 88.5%
   HNSC 2 93.2%, 85.3%
RPS3 Amplification 11q13 BRCA 2 100%
   LUNG 5 90.5%
RPS16 Amplification 19q13 LUNG 6 100%
RPL13A, RPL18, RPL28, RPS5, RPS9, RPS11, RPS16, RPS19 Deletion 19q13 GBMLGG 5 98.8% - 99.4%
RPL11, RPL22, RPL5, RPS8 Deletion 1p GBMLGG 5 97.5%
RPS24 Deletion 10q22 GBMLGG 3 90.5%
  1. Some tumor clusters were significantly associated with greater incidence of copy number alterations than other tumors from the same cancer cohorts (α <  0.01); clusters with > 90% of tumors possessing a given copy number alteration are included in this table. Cancer cohorts with no tumor clusters strongly associating with a RP copy number alteration were excluded from this table